HAEMONETICS CORP — Director's Dealing 2018

Jun 8, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2018-06-06

Reporting Person: Goldstein Dan (VP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-06	Common Stock	M	2607	$34.42	Acquired	6288	Direct
2018-06-06	Common Stock	M	1106	$41.64	Acquired	7394	Direct
2018-06-06	Common Stock	S	2607	$95.14	Disposed	4787	Direct
2018-06-06	Common Stock	S	1106	$95.14	Disposed	3681	Direct
2018-06-07	Common Stock	S	81	$92.73	Disposed	3600	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-06	Non-qualified Stock Option (Right to Buy)	$34.42	M	2607	Disposed	2023-04-06	Common Stock (2607)	Direct
2018-06-06	Non-qualified Stock Option (Right to Buy)	$41.64	M	1106	Disposed	2024-06-06	Common Stock (1106)	Direct

Footnotes

F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2018.

F2: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.